DrugDashboards

Leader Eye Drops Redness Relief

Glycerin, Naphazoline hydrochloride · GLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mL · Solution/ Drops · Ophthalmic · Cardinal Health

NDC 70000-0010-01 · 1 BOTTLE, PLASTIC in 1 CARTON / 15 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1048 per mL over the past year. A Class II recall hit this product in the past year (K.C. Pharmaceuticals, Inc). Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Jan 2021Sep 2026$0.1048
47 price points · per MLSource: CMS NADAC

Medicaid spend (2022)

$312
24 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

15Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • Class I/II recall in past 12 months+15

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for glycerin, naphazoline hydrochloride (other) in the next 90 days

sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M018
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingMar 3, 2026
    K.C. Pharmaceuticals, IncLack of Assurance of Sterility

Manufacturers of Glycerin, Naphazoline hydrochloride (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Grandall Distributing Co., Inc.GLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 3, 2026
Better Living Brands LLCGLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 2, 2026
Cardinal HealthGLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 2, 2026
Discount Drug Mart, Inc.GLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 2, 2026
Harris Teeter, LLC.GLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 2, 2026
Target CorporationGLYCERIN 500 mg/100mL; NAPHAZOLINE HYDROCHLORIDE 30 mg/100mLJul 15, 2026Sep 2, 2026
The Kroger Co.GLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 2, 2026
United Natural Foods, IncGLYCERIN .25 g/100mL; NAPHAZOLINE HYDROCHLORIDE .012 g/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Leader Eye Drops Redness Relief — NDC 70000-0010-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70000001001.

Free to cite with attribution — see how the data is put together.